Trial Profile
A crossover study of rosuvastatin and pitavastatin in patients with type 2 diabetes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Mar 2011
Price :
$35
*
At a glance
- Drugs Pitavastatin (Primary) ; Rosuvastatin (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- 17 Mar 2011 New trial record